Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China
· Delayed Price · Currency is CNY 28.57
+0.72 (2.59%)
At close: Mar 10, 2026
Enwei Pharmaceutical Market Cap
Enwei Pharmaceutical has a market cap or net worth of 2.89 billion as of March 10, 2026. Its market cap has increased by 20.17% in one year.
Market Cap
2.89B
Enterprise Value
2.55B
Revenue
888.64M
Ranking
n/a
PE Ratio
54.82
Stock Price
28.57
Market Cap Chart
Since September 21, 2022, Enwei Pharmaceutical's market cap has decreased from 3.07B to 2.89B, a decrease of -5.85%. That is a compound annual growth rate of -1.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 2.89B | 8.06% |
| Dec 31, 2025 | 2.67B | 15.83% |
| Dec 31, 2024 | 2.31B | -20.75% |
| Dec 29, 2023 | 2.91B | 4.40% |
| Dec 30, 2022 | 2.79B | -9.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hainan Huluwa Pharmaceutical Group | 2.83B |
| Guhan Pharmaceutical Group | 2.96B |
| Hainan Shuangcheng Pharmaceuticals | 2.97B |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 3.03B |
| Shaanxi Kanghui Pharmaceutical | 2.75B |
| Zhejiang Shapuaisi Pharmaceutical | 2.73B |
| Ginwa Enterprise (Group) | 3.10B |
| Anhui Fengyuan Pharmaceutical | 3.14B |